Search

everythinglearnresearchcommunity

for

Search:↓

Garudan Kizhangu Ennai may effectively treat alopecia areata but needs more research to confirm its safety and effectiveness.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Quercetin effectively treated and prevented hair loss in mice.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

New regenerative treatments for hair loss show promise but need more research for confirmation.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

New drugs for heart disease may be developed from molecules secreted by stem cells.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Somatostatin may help protect hair follicles from immune attacks.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.